Milwaukee area biotech ZyStor seeks more funding
Wauwatosa, Wis. ZyStor
Therapeutics, Inc. will seek additional venture funding this year in advance of filing for an investigational new drug application, president and CEO Loren G. Peterson said.
Peterson explained the company's plans during an informal gathering at the Innovation Monday p...
Dan Broderick Joins Prolog Ventures as Partner
...rough MHIN that Broderick developed a close rapport with
Prolog's other partners -- Ilya Nykin and Brian Clevinger. After
Broderick's fund invested in zystor
Therapeutics, one of the most promising
ventures in Prolog's portfolio, he joined Clevinger on the company's board
of directors. The two also have ser...
Wisconsin VCs draw Missouri biotech firm to state
... The Milwaukee County Research Park Center. zystor
will have labs at the research park. An investmen...ve from Wisconsin. Investors formed a new company, zystor
Theraputics, to buy Symbiontics intellectual prope... stripped away in the liver, Broderick said, while zystor
will use proteins, which are expected to survive l...
Life-sciences conference showcases capital ideas of Wisconsin
...ntatives giving presentations. Out-of-state companies included Seattle-based ultrasound developer Mirabilis Medica, lysomal storage disease researcher zystor
Theraputics, which has relocated Missouri-based technology to Wisconsin, and Pennsylvania-based drug manufacturer NeuroGenomeX .
ZyStor receives first funding and buys theraputics for rare diseases
... Milwaukee zystor
Theraputics, Inc., has received an undisclosed pie...Wisconsin investment that caught its attention. zystor
expects to file an investigational new drug applic...atment for a year runs $160,000.
The technology zystor
bought from Symbiontics is called glycosylation in...
Milwaukee research alliance sees need for incubator
...re was a dearth of laboratory space available for laboratories to move in," said Dan Broderick, a managing director of Mason Wells. Read more about zystor
relocation. For Milwaukee to compete, we need an incubator, Broderick said. Were supportive, because we plan on investing in the state of Wisconsin...
2004 in review: Editors picks
Wisconsin investors also brought the technology of a St. Louis company, Symbiontics Inc., to Milwaukee with an $8.5 million financing round, forming zystor
Theraputics to carry on its work in treating rare, fatal diseases.
Read more in health technology and biotech .
Tom Still, pre...
VC trends, company progress discussed at Mason Wells portfolio meeting
...e contacted the company to explore both IPO and acquisition strategies.
Therapeutics : A recent transplant from Missouri to Wisconsin, zystor
reported that tests of its therapeutics for lysosomal storage diseases have...
ZyStor to exhibit cell disorder treatments
...kee, Wis. - Loren Peterson, president and CEO of zystor
Therapeutics, Inc. is looking forward to showcasi...isease at the University of Florida .
is doing animal studies in collaboration with St.... from commercialization. After the animal studies, zystor
will have to put together an investigational drug ...
ZyStor seeks to raise $15M for clinical trials
...o raise more venture capital for clinical trials, zystor
Therapeutics will be one of 30 firms presenting a...loping its response to Lysosomal Storage Diseases, zystor
is targeting a class of more than 40 genetic disea... Venture Investors, is impressed with the progress zystor
has made, especially given the fact that developin...